This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
After earning a degree in Computer Science and working for multiple technology startups, Shakir first came to the Broad to work on a project studying human genetic variation called the 1000 Genomes Project, which launched in 2008. We’re reusing open-source software that other people have built and adapting it to further bioinformatic science.
Founded in 2008, Gubra is a privately-held biotech company located in Denmark delivering scientific counselling, contract research services, and projects for co-development in four main focus areas: Obesity, diabetes, NASH and diabetic complications. About Gubra.
These laboratories share data and bioinformatics tools that enabled the early detection of SARS-CoV-2 and monkeypox even before their reference genomes were available. At least nine laboratories outside the U.S. Federally funded laboratories must also deposit genetic sequences into public databases, such as GISAID and GenBank.
Nature Reviews Molecular Cell Biology (2008). Drug Discovery Today: Disease Models (2008). Molecular Systems Biology (2008). Link Modelling and analysis of gene regulatory networks , by Karlebach G. & & Shamir R. Link Artificial Gene Regulatory Networks—A Review , by Cussat-Blanc S. Artificial Life (2018).
Nature Reviews Molecular Cell Biology (2008). Drug Discovery Today: Disease Models (2008). PNAS (2008). Molecular Systems Biology (2008). Link Modelling and analysis of gene regulatory networks , by Karlebach G. & & Shamir R. Link Artificial Gene Regulatory Networks—A Review , by Cussat-Blanc S.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content